Annis Gardner Whiting Capital Advisors, LLC Novartis Ag Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $357 Billion
- Q4 2024
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 379 shares of NVS stock, worth $42,103. This represents 0.01% of its overall portfolio holdings.
Number of Shares
379
Previous 379
-0.0%
Holding current value
$42,103
Previous $43.6 Million
15.4%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding NVS
# of Institutions
1,478Shares Held
130MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.36 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.22 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$909 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$763 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$620 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $239B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...